The CXCR4 antagonist plerixafor (AMD3100) promotes Proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling

Berning Philipp, Schaefer Christiane, Clemens Dagmar, Korsching Eberhard, Dirksen Uta, Potratz Jenny

Research article (journal) | Peer reviewed

Details about the publication

JournalCell Communication and Signaling (Cell Commun Signal)
Volume16
Issue21
StatusPublished
Release year2018 (18/05/2018)
Language in which the publication is writtenEnglish
DOI10.1186/s12964-018-0233-2

Authors from the University of Münster

Berning, Philipp
Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A)
Dirksen, Uta
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)
Korsching, Eberhard
Institute of Bioinformatics
Potratz, Jenny Charlotte
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)
Schaefer, Christiane
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)